Wealth Enhancement Trust Services »

Fate Therapeutics shares owned by Wealth Enhancement Trust Services

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Wealth Enhancement Trust Services from 13F filings

Historical chart of Wealth Enhancement Trust Services investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Wealth Enhancement Trust Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Wealth Enhancement Trust Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $931 345 2.70

More positions owned by Wealth Enhancement Trust Services

Two Rds Shared Tr Anfield Unvl Etf (AFIF)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ssga Active Etf Tr State Street Mul (RLY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wisdomtree Tr Japn Hedge Eqt (DXJ)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wealth Enhancement Trust Services

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics